RANI
Rani Therapeutics Holdings Inc
NASDAQ: RANI · HEALTHCARE · BIOTECHNOLOGY
$0.94
+5.87% today
Updated 2026-05-01
Market cap
$108.42M
P/E ratio
—
P/S ratio
66.39x
EPS (TTM)
$-0.45
Dividend yield
—
52W range
$0 – $4
Volume
1.1M
Rani Therapeutics Holdings Inc (RANI) Financial statements
SEC filings — annual and quarterly data.
Balance sheet — annual
| Item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
| Total assets | $23.02M | $79.42M | $124.21M | $108.03M | $57.92M | $36.63M |
| Cash & equivalents | $16.54M | $73.06M | $117.45M | $27.01M | $5.86M | $3.76M |
| Current assets | $16.94M | $74.94M | $119.59M | $100.92M | $50.85M | $29.74M |
| Total liabilities | $119.66M | $192.75M | $2.64M | $34.02M | $32.47M | $33.14M |
| Current liabilities | $3.50M | $5.31M | $2.64M | $4.82M | $7.99M | $19.89M |
| Long-term debt | — | $2.41M | — | $29.15M | $24.48M | $9.61M |
| Shareholder equity | $-96.64M | $-113.34M | $47.41M | $36.85M | $12.87M | $1.99M |
| Retained earnings | $-97.30M | $-114.00M | $-8.33M | $-38.92M | $-72.89M | $-102.91M |
| Accounts receivable | $250000.00 | $1.72M | — | — | $200000.00 | $428000.00 |
| Inventory | $1.00 | — | — | — | — | — |
| Goodwill | — | — | — | — | — | — |